Oracle Health Sciences
has strengthened its analytics offerings with the release of
Oracle® Clinical Development Analytics 2.0
and
Oracle Life Sciences Data Hub 2.1.4
.
Oracle’s life sciences analytics solutions help organizations accelerate insight and increase research and development efficiency. Oracle Clinical Development Analytics 2.0 expands beyond the product’s original focus on clinical data management to provide rich content for clinical operations.
With more than 360 pre-built and pre-sourced metrics and associated attributes, Oracle Clinical Development Analytics 2.0 enables life sciences organizations to gain insight into trial and program performance and make more informed business decisions by helping them to:
For comprehensive insight across the clinical trial environment, Oracle Clinical Development Analytics 2.0 now sources data directly from Oracle’s Siebel Clinical Trial Management System, in addition to information from Oracle Clinical and Oracle Remote Data Capture.
Oracle Life Sciences Data Hub 2.1.4 is a validated and secure data repository that integrates clinical, non-clinical and safety data from multiple sources into a unified environment. This helps enable organizations to streamline business processes around trial data acquisition, analysis and reporting. Updates to the latest version help:
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.